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Thymus-derived lymphocytes are important regulatory cells in the lymphohe- 
matopoietic system. Subsets of T  cells are crucial elements in both humoral and 
cellular immunity (1), as well as in the regulation of hematopoietic cell differen- 
tiation (2).  Among the myeloid lineages, T  cells or their products stimulate the 
early phases of erythroid differentiation (3), as well as influencing granulocyte 
(4)  and  eosinophil  differentiation  (5).  Moreover,  T  cell  subsets  can  inhibit 
erythroid progenitor cell development (6). 
Antigens encoded by the I region of the murine major histocompatibility locus 
are known as Ia antigens. These cell surface proteins are important in immune 
modulation, as they regulate or restrict specific cellular interactions that occur 
during the immune response (7).  Ia antigens exist on both murine and human 
hematopoietic cells. The expression of Ia antigens on these cells is transient, and 
occurs at specific early stages of hematopoietic differentiation (8).  Thus, in the 
erythroid  lineage,  Ia is expressed on primitive progenitor cells (burst-forming 
unit of erythrocyte [BFU-E]I),  and is lost during differentiation to the colony- 
forming  progenitor  cell  (CFU-E)  (9).  The  colony-forming  unit  of  granulo- 
cyte/macrophage (CFU-GM) also bears this antigen (10). During differentiation, 
Ia  is  lost in the granuiocytic lineage,  but is  retained during differentiation of 
these progenitor cells to macrophages (1 1). 
A  relationship exists between  the expression of Ia antigens and the stage of 
the  cell  cycle  (12).  Human  multipotent  (CFU  of granulocytes,  erythrocytes, 
macrophages, and megakaryocytes [CFU-GEMM]), erythroid (BFU-E), and gran- 
ulocytic (CFU-GM) progenitor cells express Ia antigens transiently during phases 
of DNA synthesis (13,  14).  Moreover, both Ia expression and colony formation 
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by CFU-GM are sensitive to in vitro hematopoietic regulatory activities such as 
acidic isoferritins (14) and prostaglandins of the E series (15). 
Little  information  exists  concerning  the  involvement  of immunoregulatory 
cells  in  the  regulation  of megakaryocytopoiesis.  The  frequent  observation  of 
thrombocytosis secondary to infection or inflammatory response is suggestive of 
such  interactions.  We  report  that  mitogen-activated  murine  T  lymphocytes 
produce a factor(s) involved in megakaryocyte (Mk) differentiation. Using mon- 
oclonal  antibodies  (mAb),  we  show  that  a  subpopulation  of murine  CFU-Mk 
express Ia antigens, and that this expression is related to cell cycle status (DNA 
synthesis).  Finally, this T  cell-derived regulatory activity is  shown to concomi- 
tantly increase CFU-Mk  Ia expression and  DNA  synthesis.  These observations 
suggest that the immune system is capable of augmenting basal levels of throm- 
bopoiesis. 
Materials and Methods 
Hematopoietic Progenitor  Cell Assays.  Bone  marrow  cells  obtained  from  femurs  of 
specific pathogen-free, 4-8-wk-old male  mice (C57BL/6,  Charles  River Laboratories, 
Inc., Wilmington,  MA)  were suspended  in  McCoy's 5A  medium  (Gibco Laboratories, 
Grand Island, NY) and monodispersed. Before plating, the cells were incubated at 37 °C 
for 30-45 min at ~5  x  10  6  cells/ml in McCoy's 5A medium containing  10% fetal calf 
serum  (FCS)  (HyClone,  Logan,  UT).  CFU-Mk  assays  were  performed as  previously 
described (16). Briefly, 3-5 x  104 total nucleated cells were cultivated in modified McCoy's 
5A medium containing  10%  fetal calf serum,  0.25% bacto agar (wt/vol) and 7.5-20% 
(vol/vol) stimulatory activities (see  below).  Following incubation (7  d,  7%  CO2,  100% 
humidity)  cultures  were  removed  from  the  incubator,  air  dried,  stained  in  situ  for 
acetylcholinesterase activity, and counterstained with hematoxylin (17).  Colonies were 
counted at x  40. 
Conditioned Media (CM).  Growth of murine Mk colonies requires two activities. Mk 
colony-stimulating activity (Mk-CSA)  is found in CM  from the WEHI-3 murine mono- 
myelocytic leukemia line (18), or as an activity associated with the interleukin 3 (IL-3) 
molecule (19). Optimal growth of murine Mk colonies requires an additional activity (Mk- 
potentiator activity) found in mouse lung conditioned media (MLuCM) (20, 21), or can 
be substituted for by the  active tumor-promoting phorbol diesters (phorbol myristate 
acetate [PMA]) (22). 
WEHI-3 cells were adapted to ~rowth in suspension culture (23). Cells were grown in 
McCoy's 5A containing 5  X  10-  M  2-mercaptoethanol and  2% fetal calf serum. The 
medium was harvested every 3-4 d, and concentrated fivefold by ultrafiltration (YM-10; 
Amicon Corp., Danvers, MA).  MLuCM was prepared by coarsely cutting murine lungs 
and suspending one lung in 5 ml McCoy's 5A medium. The CM were collected after 3- 
4 d of incubation. Optimal concentrations of these CM were determined using reciprocal 
titrations (24). The concentrations used most typically were: 2.5-10% (vol/vol) WEHI-3- 
CM, 7.5% (vol/vol) MLuCM. (PMA) (Sigma Chemical Co., St. Louis, MO) was prepared 
as a stock solution of 10  -5 M in dimethyl suifoxide, and kept in the dark at -20°C until 
used. Fresh stock solutions were prepared every 3 wk. Immediately before use, a working 
solution was prepared using McCoy's 5A medium as the diluent. PMA serves as a powerful 
differentiation agent for murine Mk colonies (21).  As such, it substitutes in these assays 
for MLuCM. 
Preparation and Characterization of Murine T Cell Hybridomas.  T  cell hybridoma FS7- 
20 and its subclones are the products of the fusion of normal B 10.BR T  cells to the AKR 
thymoma BW5147.  This hybridoma was generously supplied by P.  Marrack (National 
Jewish Hospital, Denver, CO). A subclone of this hybridoma (FS7-20.6.18) elaborates Ia- 
inducing factor (Ia-IF), macrophage activating factor (MAF),  and 3' interferon (IFN-3") 
after stimulation  with  concanavalin A  (Con A)  (25).  An  independently derived T  cell LONG AND  SHAPIRO  2055 
hybridoma  (FS7-6.18)  is  also  inducible  with  Con  A  and  produces  IL-2  and  B  cell 
differentiating  factor  (26).  Another  T  cell  hybridoma  (FS6-14.3)  and  gibbon  T  cell 
lymphoma line MLA-144 produce lectin-free IL-2 (27, 28). 
Hybridoma cells (5 ×  105 cells/ml) were grown in Iscove's modified Dulbecco's medium 
(Gibco Laboratories) containing  10%  FCS and  4  t~g/ml Con  A.  CM  was harvested  by 
centrifugation at 24 h, and  10 mg/ml a-methyl mannoside was added to inhibit Con A 
activity. 
Hybridoma Antibody Reagents.  To aid in determining the importance of the Ia expres- 
sion during Mk growth and differentiation, a number ofanti-Ia hybridoma reagents were 
used.  Hybridomas 25-9-3 (I-Ab),  25-5-16 (I-Ab), and 25-9-17 (I-A  b) were obtained from 
the American Type Culture Collection (Bethesda,  MD) (29).  Hybridomas 14-4-4 (I-E  TM) 
and 10-2-16 (I-A  k'r's) were obtained from the Salk Institute (La Joila, CA) (30). Hybridoma 
supernatants were used in cytotoxicity studies at I 0-15% final concentration (vol/vol). 
Cell Separation.  Bone marrow adherent cells were collected by plastic adherence as 
described previously (22).  Briefly, murine bone marrow cells were incubated (3  ×  105 
cells/ml)  in  McCoy's  5A  medium  containing  5%  FCS  for  1  h  at  37°C,  after  which 
nonadherent ceils were removed and subjected to a second adherent step. Adherent cells 
were detached using a rubber policeman. Adherent cell-depleted bone marrow ceils were 
collected  after the  second  depletion,  and  used  as  a  source  of progenitor  cells  in  the 
overlayers of subsequent feeder-layer experiments (vide infra). Unless otherwise stated, 
all assays used adherent cell-depleted bone marrow as the target cell population. T  cell- 
enriched  populations  were  obtained  by  subjecting  murine  spleen  cells  to  nylon  wool 
adherence to deplete B lymphocytes and macrophages (32). Where necessary, nylon wool- 
depleted  lymphocytes  were  subjected  to  a  round  of plastic  adherence  and  immune 
depletion of T  cells and B cells by complement-dependent mAb cytotoxicity (vide infra). 
Preparation of Purified Cell Populations.  Purified T  cells (<1% contaminating macro- 
phages) were prepared by passing a single-cell suspension of spleen cells over nylon wool 
columns. Cells collected in the first 15 ml effluent from the column were further depleted 
of macrophages by two  30-min  incubations  in  the presence  carbonyl iron  (Atomergic 
Chemetals Corp.,  Plainview,  NY) and phagocytic cells removed with a  strong magnet. 
Cells incorporating latex particles and having morphologic characteristics of macrophages 
comprised <1% of this population. B cells were depleted by treatment of this macrophage- 
depleted population with rabbit anti-mouse IgG serum (1:100 final dilution) and rabbit 
complement (RC') as previously described (33).  This B cell and macrophage-depleted 
population was used as a  source of purified T  cells.  Purified T  cells (5  ×  105 cells/ml) 
were activated with 4/~g/ml Con A for 24 h, and used in feeder-layer experiments. For 
experiments requiring T  cell depletion, these cells were treated with anti-Thy-l.2 serum 
(1 : 10 final dilution) and (RC'). 
Feeder-layer  Experiments.  The ability of nonadherent bone marrow cells to respond to 
T  cell products was examined in feeder-layer experiments. Purified T  cells were used as 
stimulator cells and examined for their ability to produce soluble factors in response to 
the  T  cell  mitogen  Con  A.  Mitogen-activated  T  cells  were  cultured  at  various  cell 
concentrations (3-10 ×  105 cells/ml) suspended in McCoy's 5A medium containing 0.5% 
agar and plated as feeder layers. Adherent cell-depleted overlayers containing 5.0 ×  104 
bone  marrow  ceils  suspended  in  0.3%  agar  were  used  as  the  target  cell  population. 
Relevant controls consisted of feeder layers without cells in the overlayer, thereby insuring 
that  the  adherent  cells  contained  no  progenitor  cells,  as  well  as  cultures  containing 
adherent cell-depleted marrow cells,  to assess spontaneous Mk colony growth. Previous 
studies  (22)  have indicated  that  neither  of these  controls supports  Mk  or granulocyte 
colony development. 
In experiments designed to determine whether or not mitogen-stimulated T  cells were 
capable of elaborating Mk regulatory activities, each of the two activities required  for 
optimal Mk colony formation were added individually to the cultures. Thus, a source of 
Mk-CSA (WEHI-3-CM) was added to determine whether or not the Con A-stimulated T 
cells produced  Mk potentiator activity. Conversely, a  source of Mk potentiator activity 2056  T  CELLS  AND  MEGAKARYOCYTOPOIESIS 
(either  10  -6 M  PMA or MLuCM) was added to determine  whether or not the mitogen- 
activated T  cells could produce Mk-CSA. 
Antibody-dependent  Cellular Cytotoxicity.  The presence of la antigen on murine mega- 
karyocyte progenitor (CFU-Mk) cells was determined using anti-Ia mAb in complement- 
dependent cytotoxicity assays. Murine bone marrow cells (7.0 ×  106 cells/ml) were treated 
with anti-Ia mAb diluted  l:l,q in serum-free McCoy's medium containing RC'  (diluted 
1:20). This suspension  was incubated at  37°C  for 30  rain,  the cells were washed three 
times  in  serum-free  McCoy's  5A,  and  were  resuspended  in  1-2  ml  of McCoy's  5A 
containing  10% FCS. Controls for these experiments were bone marrow cells incubated 
in RC' only, as well as cells incubated in the presence of RC' and an inappropriate anti- 
Ia mAb (secreted by hybridomas  14-4-4 and  10-1-16, see above). The antibody-treated 
cells or controls were then assayed for CFU-Mk as described above. 
The percentage of CFU-Mk expressing  Ia antigen was determined by the percent of 
cytotoxicity occurring  in  anti-Ia-treated  bone  marrow  cells  as  compared  to  the  cells 
treated with RC' alone. Treatment with RC' alone resulted in 2.6 _  10.0% nonspecific 
killing of CFU-Mk (n -- 6 experiments of three to five replicate cultures per experiment). 
Sensitivity  of CFU-Mk  to  5-Hydroxyurea  (5-HU) (Cell Cycle Status).  The  proportion  of 
CFU-Mk synthesizing  DNA in  vivo was determined  by injection  of 5-HU  (900  mg/kg 
i.p.), as described previously (34). The mice were killed 3 h after injection, and the femurs 
were excised and flushed into McCoy's 5A medium.  CFU-Mk assays were performed as 
described above. Control animals received an equal volume of phosphate-buffered saline 
(PBS). 5-HU-mediated progenitor cell cytotoxicity was determined by comparison of the 
total number of CFU-Mk per femur between control and 5-HU-treated animals. 
To determine the in vitro cell cycle status of CFU-Mk, murine bone marrow suspensions 
were  treated  in  vitro  with  2  ×  10  -~  M  5-HU  (35).  Murine  bone  marrow  cells  were 
incubated in the presence or absence of 5-HU for 30 rain at 37°C, and assayed for CFU- 
Mk as described.  In certain experiments,  C57BL/6 mice were treated with 5-HU in vivo 
(to  remove cells  synthesizing  DNA); the  femurs  were  excised,  flushed,  an  aliquot  was 
cultured  for CFU-Mk and  the  remainder  were  tested  for Ia  expression  using in  vitro 
antibody-dependent cytotoxicity assays. 
Effects of T Cell Products on CFU-Mk.  In testing the actions of T  cell products on both 
Ia expression and cell cycle status, adherent cell-depleted, T  cell-depleted murine bone 
marrow  cells  were  incubated  in  the  presence  or  absence  of the  appropriate  T  cell- 
conditioned medium (i.e.  the  T  cell-CM  known to contain Mk-potentiator activity; see 
Results) at 37 °C for 60 rain. Following incubation, these cells were washed three times in 
serum-free McCoy's 5A, resuspended in supplemented  McCoy's 5A medium, assayed for 
Mk progenitor cell numbers (input), and subsequently tested for either Ia expression or 
5-HU sensitivity, as described. Finally, to determine the relationship between Ia expression 
and cell  cycle status,  studies  were  performed  in  which adherent  cell-depleted,  B  cell- 
depleted,  and T  cell-depleted  murine bone marrow cells were first incubated  (with or 
without)  T  cell-CM,  treated  in  an  antibody-dependent  anti-Ia  cytotoxicity assay,  and 
subsequently  subjected  to in  vitro  5-HU  cytotoxicity.  In all  of these  experiments,  the 
appropriate controls were subjected to 5-HU sensitivity as well. 
Results 
Stimulatory  Activities  Found in  T  Cell Hybridoma-CM.  CM  from three  T  cell 
hybridomas were analyzed for their solitary ability to support Mk colony growth 
(i.e.,  the ability  to function  as an  IL-3-1ike molecule  or source  of Mk-CSA),  or 
for their ability to augment Mk colony formation when cocultured with a known 
source  of Mk-CSA,  such  as  WEHI-3-CM,  (i.e.,  Could  these  CM  function  as  a 
source of Mk potentiator activity?). CM from one of the three T  cell hybridomas 
(FS7-20.6.18)  was found to augment  Mk colony formation,  but  lacked  the sole 
ability  to  support  Mk  colony  development  (Fig.  I).  Culture  of murine  bone 
marrow  cells  in  the  presence  of WEHI-3-CM  alone  generated  10.0  +__  3.0  Mk z  40 
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FIGURE  1.  Augmentation ofmurine Mk colony formation by various CM. Mk colonies grown 
as  in  Materials and  Methods.  Adherent cell-depleted bone marrow  cells (50,000  cells/ml) 
cultured in the presence of WEHI-3-CM (7.5% vol/vol) only (Alone) or cocultured with WEHI- 
3-CM and MLuCM,  PMA, or T  cell hybridoma (FS7-20.6.18)-CM.  Colony numbers grown 
in the presence of MLuCM, PMA, or T celI-CM are significantly greater than colonies formed 
in the presence of WEHI-3-CM only (p -< 0.05, Student's t test). These three activities (PMA, 
MLuCM, and T  cell-CM) lack the sole ability to stimulate colony formation (see Table 2). 
colonies per  105 total  nucleated  cells (105 TNC).  When  cultured with  optimal 
concentrations of WEHI-3-CM (2.5% final concentration),  CM from this T  cell 
hybridoma resulted in 25.7 +  6.7 Mk colonies from  105 TNC. This T  celI-CM 
augmented  Mk colony development to a  degree similar  to that  of MLuCM or 
10 -6 M PMA. MLuCM is a standard biological source of Mk potentiator activity 
(16, 24), and  PMA is capable of substituting for this activity in vitro (22). The 
effect(s) of this Con A-stimulated T  cell hybridoma-CM were not eliminated in 
the presence of 10 mg/ml of 0t-methyl mannoside,  the competing sugar for the 
Con A lectin (data not shown). Conversely, CM from two other T  cell hybridomas 
(FS7-6.18,  FS6-14.13),  or gibbon T  cell lymphoma line  MLA-144 (a source of 
lectin-free IL-2) were unable to support Mk colony formation (data not shown), 
nor could they augment  colony formation  in  the presence of a  source of Mk- 
CSA (WEHI-3-CM) (Fig. 2). 
The  responsiveness  of murine  CFU-Mk to varying concentrations  of T  cell 
hybridoma-CM  is  indicated  in  Fig.  2.  The  active  hybridoma  (FS7-20.6.18) 
augmented  Mk  colony  formation  from  ~0.15-20%,  (vol/vol),  with  optimal 
activities detected at  2.5-5.0%,  final  concentration.  No activity was seen  with 
the other CM. 
Con A-activated T Cells Produce Mk Regulatory  Activities.  To establish whether 
this stimulatory activity was an intrinsic activity of the T  hybridoma, or whether 
it could also be produced by syngeneic  murine  T  cells,  T  cells were purified, 
stimulated with Con A, and established as feeder layers at varying cell concen- 
trations using adherent cell-depleted bone marrow as target cells. These feeder 
layers were examined for their ability to augment Mk colony formation.  Synge- 
neic  T  cells  were  found  to  produce  Mk  potentiator-like  activity  only  when 
stimulated with the T  cell mitogen Con A (Table I). The ability of T  cell feeder 
layers to augment Mk colony formation varied with the concentration of T  cells 2058  T  CELLS  AND  MEGAKARYOCYTOPOIESIS 
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FIGURE 2.  Responsiveness  of murine  CFU-Mk  to  varying concentrations  of T  cell-CM. 
Progenitor cell colonies grown as in  Materials and  Methods.  Adherent cell-depleted bone 
marrow cells (50,000  cell/ml) cultured in the presence of constant amounts of WEHI-3-CM 
(7.5% vol/vol) and varying concentrations of T cell-CM. Filled circles, T  cell hybridoma FS7- 
20.6.18-CM; Open triangles, CM from T  cell hybridoma FS7-6.18; Closed triangles, T  cell- 
CM from hybridoma FS6-14.3; Open squares, CM from gibbon T  cell lymphoma line MLA- 
144. On the abscissa,  relative concentration of 1.0,  10% (vol/vol) final concentration. 
TABLE  I 
Augmentation of Mk Colony Formation  by T Cell Feeder Layers 
Stimuli 
Concentration of T  cells in feeder layer 
(TNC/ml ×  10 -5) 
0.5  1.0  2.5  5.0  10.0 
Con A +  WEHI-3-CM*  36.7 +  6.0*  50.0 +  2.1  62.0 +  6.1  42.6 _  7.6  35.0 +  8.8 
Con A§  0  0  0  0  0 
WEHI-3-CM H  13.5 +  4.9  14.0 _+ 2.8  9.2 +  4.7  9.0 _  4.4  7.0 _  2.6 
Media  ~  0  0  0  0  0 
Syngeneic splenic T  cells (prepared by plastic and nylon wool adherence) were established at the 
above concentrations  in  feeder layers of McCoy's 5A  media  containing 0.5%  agar.  Overlayers 
contained  10 s adherent  cell-depleted bone marrow cells in McCoy's 5A containing 0.3%  agar. 
Values are mean ___ SD based on two experiments of 3-5 replicate cultures per condition. 
* Con A-activated T  cells in feeder layer in the presence of a source of Mk-CSA (WEHI-3-CM [5% 
vol/vol]). 
*p _< 0.05 comparison is to WEHI-3-CM at each given T  cell concentration. 
§ Con A-stimulated T  cells cultured without WEHI-3-CM. 
H  Cultures containing quiescent T  cells in the feeder layer plus WEHI-3-CM. 
Cultures containing overlayer and feeder layer cells without stimuli. 
in  the feeder  layer,  whereas  quiescent  (nonstimulated)  T  cells were  incapable  of 
producing  this  activity.  Maximal  stimulation  occurred  with  2.5  ×  105  T  cells 
within the feeder  layer.  Con  A-stimulated  T  cells, established  as feeder  layers in 
the absence  of WEHI-3-CM,  did not support  Mk colony formation,  thus indicat- 
ing that  Con  A  could  not directly stimulate  CFU-Mk.  In addition,  Con  A  could 
not stimulate residual adherent  cells to produce  activities necessary for Mk colony 
formation.  Cultures  established  in  the  absence  of any  stimulatory  activity  (i.e., 
without  Con A  or WEHI-3-CM)  ruled out the presence  of residual or spontaneous 
CFU-Mk  present  in  these  feeder  layers,  leading  to false positive results.  Finally, 
cultures  stimulated  with  WEHI-3-CM  alone  eliminated  the possibility of sponta- LONG  AND SHAPIRO  2059 
neous production  of Mk  potentiator  activity by either  quiescent  T  cells  (in  the 
feeder layer), or by residual adherent  cells in the overlayer. 
Actions  of Recombinant IFN-3" on  CFU-Mk.  Con  A  stimulation  of this  T  cell 
hybridoma  (FS7-20.6.18)  has  been  reported  to result  in  elaboration  of IFN-3,, 
MAF,  and  IA-IF (25).  The  action  of recombinant  IFN-3,  on  murine  CFU-Mk 
was examined  to determine  if this  purified  lymphokine was responsible  for the 
Mk potentiating activity observed in T  cell hybridoma-CM.  Murine IFN-3' lacked 
the  solitary  ability  to support  Mk  colony formation  over a  range  of  10-5,000 
U/ml (Table II). This indicated that IFN-3, did not act as an Mk-CSA. Also, IFN- 
3' failed to synergize with crude  Mk-CSA (WEHI-3-CM) over the same range of 
concentrations,  showing that it  lacked  the ability  to augment  Mk  colony devel- 
opment.  In comparison, purified  IL-3 (over a  range of 2-40  ng/ml) was capable 
of solely  supporting  Mk  colony  formation,  and  this  colony  development  was 
enhanced  by  the  addition  of  10  -6  M  PMA.  Purified  human  platelet-derived 
growth factor, murine nerve growth factor, and murine epidermal growth factor 
(Sigma  Chemical  Co.),  were  used  as  specificity  controls,  and  had  no  effects  in 
this assay system. 
Ia Expression  on Murine CFU-Mk: Relation to Cell Cycle Status.  Based  on  the 
ability of T  cells to interact with cells expressing major histocompatibility complex 
antigens, CFU-Mk were studied for the expression of Ia antigens and the relation 
of Ia expression  to CFU-Mk  cell  cycle status.  In vitro cytotoxicity experiments 
using anti-Ia mAb indicated  that  24.3  _+ 6.0%  (mean  +  SD; n  =  5) of the CFU- 
Mk  expressed  Ia  antigen  on  their  surface  (Table  III).  Additionally,  in  vivo 
TABLE  II 
Responsiveness of Murine CFU-Mk to Various Regulatory Factors 
Factor 
CFU-Mk/105 TNC 
Alone*  With WEHI-3-CM*  With 10  -6 M PMA  0 
IL-3  22.8 ± 5.2  NT m  48.0 ±  13.0  ~ 
WEHI-3-CM  10.0 ± 3.0  NT  31.0 -+ 1.5  ~ 
T celI-CM  0  25.6 -  1.4  ~  1.0 ±  1.0 
20-6-18-CM  0  23.5 + 3.6  ~  0 
Murine I FN-3,  0  0  0 
PDGF  0  0  0 
NGF  0  0  0 
EGF  0  0  0 
Murine  CFU-Mk cultured  as described  in  Materials  and  Methods.  Purified  IL-3 
cultured at  10 ng/ml, WEHI-3-CM at 2.5% (vol/vol), MLuCM at 15% (vol]vol), 20- 
6-18-CM at 2.5% (vol/vol), 1FN-~' at  10-5,000 U]mt, PDGF at 20-400 U]ml, NGF 
and EGF at 10 and 100 ng]ml. Values are mean ~ SD for 2-5 separate  experiments 
of 3-5 replicate  cultures per point, except for PDGF,  NGF, and EGF, which are 
single experiments. 
Factors  cultured  alone  to  determine  their  solitary  ability  to  support  Mk  colony 
formation. 
Factors cocultured with WEHI-3-CM (a source of Mk-CSA) to test for the presence 
of Mk potentiator activity. 
Factors cocultured with  10  -6 M PMA (which augments Mk colony development)  to 
test for the presence of Mk-CSA. 
NT, not tested. 
p  _<  0.05  compared to WEHI-3-CM alone,  except  for IL-3 plus  PMA,  which  is 
contrasted to IL-3, alone. 2060  T  CELLS  AND  MEGAKARYOCYTOPOIESIS 
TABLE  III 
la Expression by Murine CFU-Mk and Its Abrogation by In Vivo 5-HU Treatment 
Anti-Ia-mediated cytotoxicity when 
treated with:  CFU-Mk/105 TNC  Reduction  (%) 
RC'  43.4 + 4.5  3.0 ±  10 
Inappropriate* mAb + RC'  41.4 ± 6.8  3.6 -  4.2 
Anti-la mAb + RC'  32.7 ± 2.6*  24.3 -+ 6.0 
5-HU Sensitivity 
In vitro treatment  In vivo treatment 
PBS  5-HU 
(CFU-Mk/105 TNC) 
RC'  43.9 _  7.05  44.7 ± 6.6 
Inappropriate* mAb  38.3 ± 8.0  40.3 -+ 5.0 
Anti-la mAb + RC'  31.3 ± 6.0  40.2 + 6.0 
Reduction  with anti-la  mAb (%): 
29.0±3.5  10.9±15.3 
Cytotoxicity assays performed as in Materials and Methods. For 5-HU experiments,  animals 
were treated for 3 h with 5-HU (900 mg/kg, i.p.), or with an equivalent  volume of PBS 
(controls). After treatment the animals were killed, and their bone marrow cells were assayed 
for la  expression  by antibody-mediated  cytotoxicity.  Values  are  mean  +  SD  for three 
experiments of 3-5 replicate cultures per point. 
* Inappropriate mAb was either 14-4-4 or 10-2-16. 
*p _< 0.05, comparing RC' vs. mAb + RC'. 
treatment  of murine  bone marrow with  5-HU resulted  in an  18.3  +  10.7  (n = 
6) reduction in CFU-Mk number  (data not shown). 
To determine  whether the progenitor cells expressing Ia were those cells that 
were  actively  synthesizing  DNA,  mice  were  treated  in  vivo  with  5-HU  (to 
eliminate  cells  in  S  phase)  (34).  Bone marrow  cells  isolated  from these  animals 
were then examined for Ia expression using an in vitro cytotoxicity assay. Control 
animals  (injected  with  PBS)  showed  the  same  proportion  of anti-Ia-mediated 
reduction in CFU-Mk number (29.0 +  3.5%; n  =  3 experiments of three animals 
each)  (Table  IlI)  as  did  the  above  studies  on  Ia  expression.  Pretreatment  of 
animals  in  vivo with  the  cell  cycle-specific agent  5-HU  abrogated  the  anti-Ia- 
mediated  cytotoxicity, suggesting that the cells in the S phase of cell cycle were 
those cells that expressed  Ia antigen. 
T  Cell Factors Regulate CFU-Mk Ia Expression and  Celt Cycle Status.  Further 
studies were undertaken  to determine whether or not the association between  Ia 
expression and cell cycle status could be mediated by T  cell factors. Murine bone 
marrow  cells  preincubated  in  CM  from  the  active  T  cell  hybridoma  (FS7- 
20.6.18),  significantly increased  expression  of the Ia antigen from 20.5  4- 4.5% 
of CFU-Mk  expressing  this  antigen  to  39.3  +  6.3%  (Table  IV).  In  separate 
studies,  preincubation  of the  CFU-Mk in this CM increased the number  of cells 
in DNA synthesis from  14.3  +  3.5 to 45.6  4- 3.5%  (Table IV). 
To more firmly establish the relationship between T  cell factors, Ia expression, 
and  cell  cycle status,  the  two  previous  observations  were  combined  in  a  single LONG  AND  SHAPIRO 
TABLE  IV 
T CeU-CM Increases In Vitro CFU-Mk Ia Expression and the 
Number of CFU-Mk in S Phase 
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Anti-la-mediated cytotoxicity when 
treated with: 
CFU-Mk/105 TNC after incubation in: 
T  celI-CM  Plain medium 
Inappropriate mAb  51.3 +  8.9  55.2 4- 12.5 
Anti-la mAb  31.3 ±  7.5  43.0 4- 9.7 
Reduction (%):  39.3 ±  6.3*  20.5 +  4.5 
5-HU sensitivity 
Before incubation with 5-HU 
After incubation with 5-HU 
43,7 +  6.6  52.8 +  21.2 
25,8 4- 10.9  43.4 4- 12.8 
Reduction (%):  45.6 ±  3.5*  14.3  ±  12.8 
Cytotoxicity assays performed as in Materials and Methods. Values are mean ±  SD 
for 3-4  separate experiments (except two experiments for anti-Ia treatment of T 
celI-CM-incubated cells) of 3-5 replicate cultures per condition. 
* p _~ 0.05 comparing T  celI-CM with plain medium for percent reduction. 
experiment. Murine CFU-Mk were preincubated in CM from .T cell hybridoma 
a  FS7-20.6.18,  subjected to anti-Ia cytotoxicity, and subsequently incubated in 
the presence of 5-HU to determine cell cycle status. These experiments indicated, 
again, that la expression was linked to cell cycle status. Ia expression on progen- 
itor cells not exposed to this active CM was 27.5%. Following exposure to T  cell 
hybridoma CM, the proportion of cells in S phase increased to 69% (Table V). 
Subsequently, treatment of T  cell hybridoma-CM-exposed progenitor cells with 
anti-Ia  mAb  abolished  the  5-HU-related  cytotoxicity (Table  V).  Therefore, 
removal of Ia ÷ cells before 5-HU Cytotoxicity removes target cells for 5-HU (i.e., 
cells in active DNA synthesis). This observation confirmed the previous in vivo 
and in  vitro results showing that  CFU-Mk in  active phases of DNA  synthesis 
express Ia. 
Discussion 
The in  vitro development of murine CFU-Mk requires the presence of two 
regulatory activities: (a)Mk-CSA, an obligate factor for the proliferation of the 
CFU in vitro (16), which is produced by WEHI-3 cells, a murine monomyelocytic 
leukemia line (23), or as an activity of the purified lymphokine I L-3 (19); and.(b) 
Mk potentiatoractivity, produced by bone, bone marrow, spleen, and lung cells 
(20,  36).  Mkpotentiator activity increases the DNA content of colony-derived 
murine  Mk  (36),  and  also directly stimulates the differentiation of immature 
murin(Mk into single, mature cells (37). The role of T  cells, or T  cell products, 
as regulators of in vitro megakaryocytopoiesis is shown by the ability of T  cell 
lymphokines to mimic potentiator activity by augmenting Mk colony formation. 
As well, T cetl products increase CFU-Mk Ia expression, and regulate the number 
of CFU.in active DNA synthesis. 
Mitogen-activated T  lymphocytes produce an activity that augments Mk colony 
formation when cocultured with a source of Mk-CSA (WEHI-3-CM). T  cells or 2062  T  CELLS  AND  MEGAKARYOCYTOPOIESIS 
TABLE  V 
Abrogation of 5-HU Sensitivity by Prior Removal of la + CFU-Mk 
Anti-Ia-mediated  cytotoxicity when  CFU-Mk/10  ~  TNC  Reduction (%) 
preincubated with T cell-CM and: 
RC'  76.0 ±  15.8  0 
Inappropriate mAb + RC'  118.0 ±  19.4  0 
Anti-Ia mAb  36.6 ±  10.4  69.0 
Preincubation  with 
plain medium and: 
RC'  35.0 ± 7.0  0 
Inappropriate mAb + RC'  64.6 + 8.6  0 
Anti-Ia + RC'  47.0 ± 5.2  27.5 
5-HU sensitivity 
Primary incubation 
CFU-Mk/IO  5 TNC 
Before incubation  After incubation 
with 5-HU*  with 5-HU  Reduction  (%) 
RC'  76.0 +  15.8  56.6 + 4.4  25.5 
Inappropriate mAb  118.0 +  19.4  47.0 ± 9.6  60,0 
Anti-la mAb  36.6 + 8.6  49.0 ± 5.8  0 
Cytotoxicity assays performed as in Materials and Methods.  In anti-la-mediated  cytotoxicity, T-, 
B-, and adherent cell-depleted marrow cells were incubated  (37°C for 1 h) in the presence  of T 
cell (20-6-18)-CM,  or in plain medium as a control. Following immunocytotoxicity,  an aliquot  of 
cells was removed for culture; the remaining cells were washed and subjected  to 5-HU sensitivity 
assays. 
* Values reported (mean + SD for a single representative  experiment)  are those for cells previously 
incubated  in T celI-CM and then subjected to anti-Ia-mediated cytotoxicity. 5-HU media controls 
(i.e., cells incubated in  media  and then  subjected  to anti-la  and 5-HU cytotoxicity) showed  no 
differences  from la-mediated  cytotoxicity alone (data not shown). 
their products lacked the solitary ability to substitute for WEHI-3-CM or IL-3 in 
stimulating CFU-Mk. These observations indicate that active T  cells produce Mk 
potentiator  activity  but  not  Mk-CSA.  The  production  of such  a  hematopoietic 
activity by T  cells  is consistent  with  reports  showing that  T  cell  subpopulations 
produce  activities  that  effect  granulocytopoiesis  (3),  as  well  as  early  phases  of 
erythroid development (4, 5). However, the restriction of Mk potentiator activity 
production  to  mitogen-activated  T  lymphocytes  is  of interest.  Hematopoietic 
factor production  in response to immunological stimulation  is variably reported 
(4,  38) in studies  of granulocytic or erythrocytic progenitor cells.  Other studies 
(39,  40) suggest that synergistic actions of macrophages and T  cells are respon- 
sible for causing the production  of hematopoietic  factors.  Such cell-cell  interac- 
tions  may be  responsible  for the  variability  noted  in  the  relationship  between 
antigen  activation and  T  cell  factor production.  We observe that bone marrow 
cells  exhaustively  depleted  of macrophages,  B  cells,  and  T  cells  retain  respon- 
siveness  to both  T  cell-CM,  MLuCM,  and  PMA  (the  latter  substitutes  for Mk 
potentiator  activity  and  is  used  as  an  internal  standard  in  these  assays).  This 
suggests  that  T  cell  factors  work directly  on  CFU-Mk.  However,  these  studies 
were carried  out on enriched  but  not purified  cell  populations,  and  used,  with LONG AND SHAPIRO  2063 
few exceptions, CM rather than purified biological activities. These limitations 
make direct assessment of the actions of T  cell products on CFU-Mk difficult. 
Complement-dependent cytotoxicity assays using mAb directed against appro- 
priate  Ia determinants demonstrate that a  subpopulation of CFU-Mk bears Ia 
antigens. This observation extends the role of Ia as a hematopoietic differentia- 
tion antigen to cells of the Mk lineage. Previous studies (41, 42) indicate that the 
murine pluripotent spleen CFU lack Ia antigen, but that CFU-GM possess this 
determinant (43).  Studies (13,  14) of human hematopoietic cells confirm these 
observations, and show the presence of Ia antigen on multipotent cells (CFU- 
GEMM), which are capable of trilineal expression in vitro (44), and on the BFU- 
E (9).  The Ia antigen is apparently lost at the promyelocyte level in the granu- 
locytic lineage (45), and at the CFU-E level during erythroid development (9). 
Interestingly, Rabellino et al. (46) show that -15% of mature human Mk retain 
Ia-like antigenic determinants. This suggests that this antigen may also mark a 
functional subpopulation of mature Mk. 
The frequency of CFU-Mk bearing Ia suggests that  these cells are also the 
CFU-Mk that  are in  active phases  of the cell cycle. The  relation between Ia 
expression on murine CFU-Mk and the mitotic cycle is shown by the loss of CFU- 
Mk sensitivity to  Ia antibody treatment in animals treated in vivo with 5-HU. 
The linkage between Ia expression and DNA synthesis is also demonstrated by 
in vitro studies, in which removal of Ia  + progenitor cells by antibody-mediated 
cell lysis also removed those cells that were sensitive in vitro to 5-HU. Extensive 
studies (13,  15, 47,  48) of human hematopoietic progenitor cells indicate that 
CFU-GM, BFU-E, and CFU-GEMM all express Ia antigenic determinants, and 
that  the expression of Ia  is  associated with  the  S  phase  of the  mitotic cycle. 
Moreover, the expression of these Ia-like molecules is associated with the respon- 
siveness of these progenitor cells to  known in  vitro hematopoietic regulatory 
activities such as acidic isoferritins and prostaglandins of the E  series (14,  15, 
17). 
We hypothesize that the presence of Ia molecules on the surface of cycling 
populations of CFU-Mk makes these cells important targets for immune regula- 
tion  of megakaryocytopoiesis. Studies in  which incubation  of CFU-Mk in  the 
presence of T  cell hybridoma (FS7-20.6.18)-CM  increased both Ia expression 
and the percent of CFU-Mk actively synthesizing DNA suggests that this hypoth- 
esis is correct. Studies by Torok-Storb et al. (49) and Lipton et al. (50) suggest 
that  regulation  of erythropoiesis  by  T  cell  subsets  in  humans  is  genetically 
restricted to cell-cell interaction mediated through recognition of Ia-like mole- 
cules.  Moreover, Torok-Storb et al.  (49) further suggest that the Ia molecule 
itself may function as a  cell receptor in immunoregulatory interactions. Thus, 
the apparent role of Ia antigenic determinants on the surface of CFU-Mk may 
be to serve as a determinant for immune recognition. 
T  lymphocyte-derived Mk potentiator activity seems to function by recruiting 
CFU-Mk into active DNA synthesis. Thus,  ~10-25%  of steady-state CFU-Mk 
are in S phase (24,  50).  Optimal concentrations of T  hybridoma-CM elevates 
this resting population to ~70 %, and concomitantly increases Ia expression to a 
similar level. Williams et al. (51) have suggested that in vitro Mk colony devel- 
opment is regulated, in part, by the cell cycle status of the progenitor ceils. The 2064  T  CELI.S AND  MEGAKARYOCYTOPO1ESIS 
mechanism  by which such modulation occurs may be through  regulatory mole- 
cules  interacting  with  and  stimulating  Ia + progenitor  cells  to  increase  DNA 
synthesis. 
The exact nature  of T  cell-derived  Mk potentiator activity is unknown.  We 
do not believe that the activity is IFN-3,, because recombinant IFN-')' is incapable 
of stimulating in vitro megakaryocytopoiesis. Williams et al. (51) have shown that 
a murine macropbage line (P388.D 1) also produces Mk potentiating activity (50). 
Both this macrophage line and the T  cell hybridoma (FS7-20.6.18) produce Ia- 
inducing activity that  is distinct  from IFN-3' (52).  Whether  Ia-inducing activity 
is  the  same  as  Mk  potentiating activity,  or  whether  the  various  sources  of 
potentiating activity (e.g. T  cells and macrophages) produce the same molecule 
must await purification of these activities. 
We report  that  antigen-activated  routine  T  lymphocytes produce an  activity 
that  meets  the  functional  definition  of  a  known  in  vitro  regulator  of  Mk 
development (Mk potentiator activity). Additionally, murine CFU-Mk are shown 
to bear Ia determinants,  and  the expression of this antigen  is related  to active 
DNA  synthesis.  Finally,  the  actions  of T  cell-derived  Mk  potentiator  activity 
appears  to  involve the  recruitment  of quiescent  CFU-Mk  into actively cycling 
cells. These observations strongly suggest that  the immune system can amplify 
basal levels of thrombocytopoiesis in response to immunological stimulation such 
as inflammation or infection. 
Su~ll~lalcy 
Mitogen-activated  routine  T  lymphocytes or T  ceil  hybridomas produce an 
activity  (megakaryocyte  [Mk]  potentiator  activity)  tbat  enhances  the  in  vitro 
growth  and  development  of Mk  colonies.  This  activity  was  found  in  optimal 
concentrations  (2.5%) in T  cell hybridoma-conditioned  medium,  and  was also 
produced by feeder layers of concanavalin A-activated T  cells. A subpopulation 
of routine  Mk  progenitor  cells  (colony-forming  units;  CFU-Mk)  bears  the  Ia 
antigen. Separate experiments indicated that T  cell products stimulate CFU-Mk 
by increasing  their basal levels of la expression as well as the frequency of cells 
actively synthesizing  DNA.  The  hypothesis that  the expression  of this  antigen 
was related  to  the  cell  cycle status  of these progenitor  cells was confirmed  in 
studies that indicated that ablation of actively cycling cells in vivo abrogated the 
cytotoxic effects of anti-Ia  monoclonal  antibodies.  The  interdependence  of T 
cell lymphokine regulation  of both  Ia  expression and  cell cycle status was also 
seen  in  in  vitro experiments  in  which  Ia + progenitor  cells were eliminated  by 
complement-dependent  cytotoxicity.  The  removal  of  la  +  cells  prevented  5- 
hydroxyurea-mediated inhibition of cells in S phase. We hypothesize that immune 
modulation  of megakaryocytopoiesis  occurs  via  soluble  T  cell  products  that 
augment  Mk  differentiation.  Further,  the  mechanism  of  immune  recogni- 
tion/modulation  may  occur  via  Ia  antigens  present  on  the  surface  of these 
progenitor cells. 
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